Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-31

What am I missing when the annoucement states that the losses in NZ will partially offset the tax charge on Neuren's profit for 2024? If the company tax is partially offset then the amount paid (and the credits generated as a result) would be lower? I'll admit It's been a while since I have dealt with company tax for my businesses so I am not an expert so I understand I am probably missing something... My point about it being a wierd decision and Jon's comments ruling it out due to the franking credit balance are still valid as those were his words not mine. His comments might have been made prior to the additional funds we recieved, but then the SBB was announced so I think it's pretty clear which he prefers